By Michael Susin Haleon PLC said Thursday that organic revenue for the third quarter rose, driven by increased pricing and higher volumes. The consumer-healthcare business, which was spun out of GSK P...
Tag: Haleon
Pharmaceutical Stocks GSK, Sanofi, Haleon Lose Billions As Zantac Recall Trial Looms
Pharmaceutical stocks GSK (GSK), Sanofi (SNY) and Haleon (HLN) have wiped out a combined $31 billion in market cap this week as worries mount surrounding litigation around recalled heartburn drug Zant...
GSK Spins Off $36 Billion Consumer-Healthcare Business Haleon
GSK PLC completed the spinoff of its consumer-healthcare business, a bet that greater focus on innovative drugs and vaccines will help accelerate growth at the pharmaceuticals giant. The new stand-alo...